HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bin Jin Selected Research

Neoplasms (Cancer)

11/2023MELK promotes HCC carcinogenesis through modulating cuproptosis-related gene DLAT-mediated mitochondrial function.
11/2023pH-Responsive and Actively Targeted Metal-Organic Framework Structures for Multimodal Antitumor Therapy and Inhibition of Tumor Invasion and Metastasis.
9/2023LRP1B suppresses HCC progression through the NCSTN/PI3K/AKT signaling axis and affects doxorubicin resistance.
1/2023Development and validation of prognostic risk prediction models for hepatocellular carcinoma patients treated with immune checkpoint inhibitors based on a systematic review and meta-analysis of 47 cohorts.
1/2023NOP2-mediated m5C Modification of c-Myc in an EIF3A-Dependent Manner to Reprogram Glucose Metabolism and Promote Hepatocellular Carcinoma Progression.
12/2022Laparoscopic versus open hepatectomy for intrahepatic cholangiocarcinoma in patients aged 60 and older: a retrospective cohort study.
5/2022Expression of FOXM1 and PLK1 predicts prognosis of patients with hepatocellular carcinoma.
10/2021Overexpression of HMGA1 confers radioresistance by transactivating RAD51 in cholangiocarcinoma.
11/2020Serum KIAA1199 is an advanced-stage prognostic biomarker and metastatic oncogene in cholangiocarcinoma.
4/2019Expression patterns and the prognostic value of the SMYD family members in human breast carcinoma using integrative bioinformatics analysis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bin Jin Research Topics

Disease

22Neoplasms (Cancer)
11/2023 - 11/2004
9Hepatocellular Carcinoma (Hepatoma)
11/2023 - 07/2003
7Cholangiocarcinoma
02/2024 - 01/2017
5Prostatic Neoplasms (Prostate Cancer)
02/2024 - 10/2010
5Carcinoma (Carcinomatosis)
01/2015 - 11/2004
4Carcinogenesis
02/2024 - 09/2007
4Neoplasm Metastasis (Metastasis)
11/2023 - 01/2013
4Lymphatic Metastasis
01/2022 - 11/2004
4Postoperative Pain
09/2019 - 01/2012
4Stomach Neoplasms (Stomach Cancer)
02/2010 - 10/2008
3Hypoxia (Hypoxemia)
02/2024 - 01/2013
3Pain (Aches)
01/2023 - 11/2012
3Wounds and Injuries (Trauma)
09/2019 - 08/2002
3Laryngeal Neoplasms (Laryngeal Cancer)
01/2015 - 08/2004
2Fibrosis (Cirrhosis)
10/2023 - 10/2013
2Liver Neoplasms (Liver Cancer)
01/2023 - 11/2016
2Vomiting
09/2019 - 09/2017
2Squamous Cell Carcinoma of Head and Neck
01/2015 - 01/2013
2Colorectal Neoplasms (Colorectal Cancer)
10/2010 - 06/2008
1Congenital Abnormalities (Deformity)
03/2024
1Reperfusion Injury
02/2024
1Jaw Cysts
01/2023
1Metaplasia
12/2022
1Axial Spondyloarthritis
12/2022
1Cartilage Fractures
08/2022
1Papillary Thyroid Cancer
01/2022
1Urinary Bladder Neoplasms (Bladder Cancer)
01/2022
1follicular Thyroid cancer
01/2022
1Postoperative Hemorrhage
05/2021
1Sarcopenia
01/2021
1Hip Fractures (Intertrochanteric Fractures)
11/2020
1Lung Neoplasms (Lung Cancer)
11/2020

Drug/Important Bio-Agent (IBA)

11Proteins (Proteins, Gene)FDA Link
02/2024 - 11/2004
6Biomarkers (Surrogate Marker)IBA
02/2024 - 01/2013
4AntigensIBA
08/2021 - 06/2008
3Docetaxel (Taxotere)FDA Link
01/2023 - 10/2017
2palbociclibIBA
02/2024 - 03/2023
2Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
11/2023 - 01/2022
2Therapeutic UsesIBA
11/2023 - 08/2005
2EnzymesIBA
10/2023 - 10/2010
2Sorafenib (BAY 43-9006)FDA Link
01/2023 - 01/2023
2Long Noncoding RNAIBA
01/2023 - 01/2022
2CarbohydratesIBA
08/2021 - 01/2017
2Ropivacaine (Naropin)FDA LinkGeneric
09/2019 - 09/2017
2Sufentanil (Sufenta)FDA LinkGeneric
09/2019 - 09/2017
2Messenger RNA (mRNA)IBA
04/2019 - 01/2015
2SolutionsIBA
09/2017 - 08/2002
2Saline SolutionIBA
09/2017 - 08/2002
2SurvivinIBA
01/2017 - 01/2013
2MicroRNAs (MicroRNA)IBA
11/2016 - 01/2013
2Indicators and Reagents (Reagents)IBA
12/2010 - 09/2007
1Fatty Acid-Binding ProteinsIBA
02/2024
1heparanaseIBA
02/2024
1Annexin A5IBA
02/2024
1GlucuronidaseIBA
02/2024
1Heparitin Sulfate (Heparan Sulfate)IBA
02/2024
1Phosphotransferases (Kinase)IBA
11/2023
1Pyruvate Dehydrogenase Complex (Dehydrogenase Complex, Pyruvate)IBA
11/2023
11-phenyl-3,3-dimethyltriazene (PDT)IBA
11/2023
1Reactive Oxygen Species (Oxygen Radicals)IBA
11/2023
1Metal-Organic FrameworksIBA
11/2023
1cabozantinibIBA
11/2023
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
11/2023
1ginkgolic acidIBA
10/2023
1Doxorubicin (Adriamycin)FDA LinkGeneric
09/2023
1liposomal doxorubicin (Doxil)FDA Link
09/2023
1IronIBA
01/2023
1Immune Checkpoint InhibitorsIBA
01/2023
1Glucose (Dextrose)FDA LinkGeneric
01/2023
1dezocineFDA Link
01/2023
1bone mealIBA
01/2023
1Technetium Tc 99m MedronateIBA
12/2022
1hydroxide ionIBA
12/2022
1Protons (Proton)IBA
12/2022
1Vascular Endothelial Growth Factor CIBA
01/2022
1RacivirIBA
01/2022
1AndrogensIBA
01/2022
1Transcription Factors (Transcription Factor)IBA
10/2021
1Carcinoembryonic AntigenIBA
08/2021
1AlbuminsIBA
01/2021
1Fibrinogen (Factor I)FDA Link
01/2021

Therapy/Procedure

6Therapeutics
11/2023 - 07/2003
5Hepatectomy
12/2022 - 09/2017
3Length of Stay
08/2021 - 01/2012
3Drug Therapy (Chemotherapy)
01/2019 - 01/2013
2Liver Transplantation
02/2024 - 11/2008
2Castration
01/2023 - 01/2019
2Operative Surgical Procedures
05/2018 - 01/2018
2Radiotherapy
10/2008 - 04/2007
1External Fixators
03/2024
1Bone Wires
03/2024
1Combined Modality Therapy
11/2023
1Lasers (Laser)
11/2023
1Photochemotherapy (Photodynamic Therapy)
11/2023
1Immunotherapy
09/2023
1Oral Medicine
01/2023
1Conservative Treatment
08/2022
1Splints (Splint)
08/2022
1Prostheses and Implants (Prosthesis)
11/2020
1Arthroplasty
11/2020